Ribosome structure and protein synthesis inhibitors

Details Ribosome structure and protein synthesis inhibitors Ribosome structure and protein synthesis inhibitors

2005-02-25

2010-02-23

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

07666849

ABSTRACT:
The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

REFERENCES:
patent: 5180719 (1993-01-01), White et al.
patent: 5281703 (1994-01-01), White et al.
patent: 5336768 (1994-08-01), Albrecht et al.
patent: 5466681 (1995-11-01), Krivan et al.
patent: 5693791 (1997-12-01), Truett
patent: 5866549 (1999-02-01), Or et al.
patent: 5905144 (1999-05-01), Truett
patent: 6380356 (2002-04-01), Griffin et al.
patent: 6437119 (2002-08-01), Truett
patent: 6446032 (2002-09-01), Schimmel
patent: 6468979 (2002-10-01), Pellacini et al.
patent: 6638908 (2003-10-01), Steitz et al.
patent: 6939848 (2005-09-01), Steitz et al.
patent: 6947844 (2005-09-01), Steitz et al.
patent: 6947845 (2005-09-01), Steitz et al.
patent: 6952650 (2005-10-01), Steitz et al.
patent: 2002/0022257 (2002-02-01), Suh et al.
patent: 2002/0086308 (2002-07-01), Steitz et al.
patent: 2002/0188108 (2002-12-01), Noller et al.
patent: 2003/0027315 (2003-02-01), Yonath et al.
patent: 2003/0232779 (2003-12-01), Steitz et al.
patent: 2004/0137518 (2004-07-01), Lambert et al.
patent: 2005/0234227 (2005-10-01), Steitz et al.
patent: 2006/0136146 (2006-06-01), Steitz et al.
patent: 1172374 (2002-01-01), None
patent: 1186614 (2002-03-01), None
patent: 1188769 (2002-03-01), None
patent: WO-9507271 (1995-03-01), None
patent: WO-9618633 (1996-06-01), None
patent: WO-9735195 (1997-09-01), None
patent: WO-9963937 (1999-12-01), None
patent: WO-0032619 (2000-06-01), None
patent: WO-0180863 (2001-11-01), None
Agalarov, S et al., (2000) “Structure of the S15, S6, S18-rRNA Complex: Assembly of the 30S Ribosome Central Domain,” Science vol. 288, pp. 107-112.
Agrawal, R., et al., (1998) “Visualization of Elongation Factor G on theEscherichia coli70S Ribosome: The Mechanism of Translocations,” Proc. Natl. Acad. Sci. USA vol. 95, pp. 6134-6138.
Ban, N., et al., (1998) “A 9 .ANG. Resolution X-Ray Crystallographic Map of the Large Ribosomal Subunit,” Cell vol. 93, pp. 1105-1115.
Ban, N., et al., (1999) “Placement of Protein and RNA Structures into a 5 .ANG.-Resolution Map of the 50S Ribosomal Subunit,” Nature vol. 400, pp. 841-847.
Ban, N., et al., (2000) “The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 .ANG. Resolution,” Science vol. 289, No. 5481, pp. 821-1096.
Baranov, P., et al., (1998) “The Database of Ribosomal Cross Links (DRC),” Nucleic Acids Research vol. 26, No. 1, pp. 187-189.
Brodersen, D., et al., (2000) “The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit,” Cell vol. 103, pp. 1143-1154.
Brunger, A., (1997) “Patterson Correlation Searches and Refinement,” Methods in Enzymology, vol. 276, pp. 558-580.
Brunger, A., et al., (1998) “Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination,” Acta Cryst. vol. D54, pp. 905-921.
Carter, A., et al., (2000) “Functional Insights from the Structure of the 30S Ribosomal Subunit and It's Interactions with Antibiotics,” Nature vol. 407, pp. 340-348.
Carter, A., et al., (2001) “Crystal Structure of an Initiation Factor Bound to the 30S Ribosomal Subunit,” Science vol. 291, pp. 498-501.
Cate, J., et al., (1999) “X-Ray Crystal Structures of 70S Ribosome Functional Complexes,” Science vol. 285, No. 5, pp. 2095-2104.
Clemons, W. Jr., et al., (1999) “Structure of a Bacterial 30S Ribosomal Subunit at 5.5 .ANG. Resolution,” Nature vol. 400, pp. 833-840.
Culver, G., et al., (1999) “Identification of an RNA-Protein Bridge Spanning the Ribosomal Subunit Interface,” Science vol. 285, pp. 2133-2135.
Dahlberg, A., et al., (2001) “The Ribosome in Action,” Science vol. 292, pp. 868-869.
Davies, C. et al., (1998) “Ribosomal Proteins S5 and L6: High-Resolution Crystal Structures and Roles in Protein Synthesis and Antibiotic Resistance,” Journal of Molecular Biology, vol. 279, pp. 873-888.
Di Giambattista, M., et al., (1990) “Affinity Labeling of the Virginiamycin S. Binding Site on Bacterial Ribosome,” Biochemistry vol. 29, pp. 9203-9211.
Douthwaite, (1992) “Functional Interactions within 23S rRNA Involving the Peptidyltransferase Center,”0 Journal of Bacteriology vol. 174, No. 4, pp. 1333-1338.
Douthwaite, S., et al., (1993) “Erythromycin Binding is Reduced in Ribosomes with Conformational Alteractions in the 23 S rRNA Peptidyl Transferase Loop,” Journal Mol. Biol. vol. 232, pp. 725-731.
Douthwaite, S., et al., (1995) “Recognition Determinants for Proteins and Antibiotics within 23S rRNA,” Biochem. Cell Biol. vol. 73, pp. 1179-1185.
Drenth, “Principles of Protein X-ray Crystallography,” 1994, Springer-Verlag, pp. 1-18.
Fitzhugh, A., et al., (1998) “Antibiotic Inhibitors of the Peptidyl Transferase Center. 1. Clindamycin as a Composite Analogue of the Transfer RNA Fragments L-Pro-Met and the D-Ribosyl Ring of Adenosine,” Bioorganic and Medicinal Chemistry Letters,vol. 8, pp. 87-92.
Fourmy et al. (1996) “Structure of the A Site ofEscherichia coli16S Ribosomal RNA Complexed with an Aminoglycoside Antibiotic” Science 274(5291):1367-1371.
Franceshi et al. (1993) “Towards Atomic Resolution of Prokaryotic Ribosomes: Crystallographic, Genetic and Biochemical Studies” in TheTranslational Apparatus 397-410.
Gabashvili, I., et al., (2000) “Solution Structure of theE coli70S Ribosome at 11.5 .ANG. Resolution,” Cell, vol. 100, pp. 537-549.
Garrett, R., et al., (1996) “The Peptidyl Transferase Center,” Ribosomal RNA pp. 327-355.
Garza-Ramos, G. et al., (2001) “Binding Site of Macrolide Antibiotics on the Ribosome: New Resistance Mutation Identifies a Specific Interaction of Ketolides with rRNA,” Journal of Bacteriology, vol. 183, No. 23, pp. 6898-6907.
Gonzales, R., et al., (2001) “Infections Due to Vancomycin-ResistantEnterococcus faeciumResistant to linezolid,” The Lancet vol. 357, p. 1179.
Green, R., et al., (1997) “Ribosomes and Translation,” Annu. Rev. Biochemistry vol. 66, pp. 679-716.
Gregory, S., et al., (1999) “Erythromycin Resistance Mutations in Ribosomal Proteins L22 and L4 Perturb the Higher Order Structure of 23 S Ribosomal RNA,” J. Mol. Biol. vol. 289, pp. 827-834.
Gschwend, D. et al., (1996) “Molecular Docking Towards Drug Discovery,” Journal of Molecular Recognition, vol. 9, pp. 175-186.
Guettell, R. (1996) “Comparative Sequence Analysis and the Structure of 16S and 23S rRNA,” Ribosomal RNA pp. 111-128.
Hanessian et al. (1984) “Quantamycin”: A Computer-Stimulated New-Generation Inhibitor of Bacterial Ribosomal Binding Journal American Chemical Society 106:6114-6115.
Hansen et al., “Structural Insights into Peptide Bond Formation,” Proc. Natl. Acad. Sci. USA, 99(18):11670-11675 (2002).
Hansen et al., “The Structures of Four Marcolide Antibiotics Bound to the Large Ribosomal Subunit,” Molecular Cell, 10:117-128 (2002).
Hansen, H.A.S., et al., (1990) “Crystals of Complexes Mimicking Protein Biosynthesis are Suitable Crystallographic Studies,” Bioclumica et Biophysica Acta, vol. 1050, pp. 1-7.
Hansen, L., et al., (1999) “The Macrolide-Ketolide Antibiotic Binding Site is Form

Affiliated with

Also associated with

Rating

Ribosome structure and protein synthesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ribosome structure and protein synthesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribosome structure and protein synthesis inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4211827